OpenArc Corporate Advisory’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
OpenArc Corporate Advisory's MRK Position: Q2 2026 in Review
OpenArc Corporate Advisory reduced its Merck (MRK) stake by 21% in Q2 2026, selling an estimated $1.33M and leaving 42,950 shares worth $5.52M. The position accounts for 0.07% of the portfolio, ranked #151.
OpenArc Corporate Advisory first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.53M in Q1 2026. 2,270 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- OpenArc Corporate Advisory held 42,950 shares of Merck worth $5.52M as of Q2 2026.
- OpenArc Corporate Advisory sold 11,348 Merck shares in Q2 2026, an estimated $1.33M.
- Merck made up 0.07% of OpenArc Corporate Advisory's portfolio in Q2 2026, its #151 holding.
- OpenArc Corporate Advisory first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
- OpenArc Corporate Advisory's Merck position peaked at $6.53M in Q1 2026.
- 2,270 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.